QUOTE AND NEWS
The Globe and Mail  May 2  Comment 
Parmaceutical company cites costs associated with its acquisition of Medicis
FiercePharma  Dec 19  Comment 
The layoff toll at Medicis Pharmaceutical has topped 300, the Phoenix Business Journal reports. Valeant Pharmaceuticals ($VRX), which wrapped up its buyout of the Arizona-based skin drug company last week, has cut 319 staffers--and kept 117--as it...
FiercePharma  Dec 18  Comment 
Valeant Pharmaceuticals ($VRX) isn't pussyfooting around Medicis. As the built-by-acquisition Canadian company wrapped up its deal for Medicis last week, some 200 employees were told to pack their bags. In a bid to beef up its dermatology...
Benzinga  Dec 11  Comment 
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) today announced the completion of its acquisition of Medicis Pharmaceutical Corporation ("Medicis") following the approval of the transaction by stockholders of Medicis at the special...
Benzinga  Dec 5  Comment 
Valeant Pharmaceuticals International (NYSE: VRX) announced today that the company has reached agreement on terms of a revised North American aesthetics arrangement with Galderma S.A. Under the terms of the revised agreement, Galderma will...
Benzinga  Dec 5  Comment 
As previously reported, on November 7, 2012, Q-Med AB (“Q-Med”) filed a complaint (the “Complaint”) against Medicis Pharmaceutical Corporation (NYSE: MRX) (the “Company”), HA North American Sales AB, a wholly-owned subsidiary of the...
Market Intelligence Center  Nov 16  Comment 
Medicis Pharmaceutical Corp (NYSE: MRX) closed Thursday's trading session at $42.79. In the past year, the stock has hit a 52-week low of $29.76 and 52-week high of $43.70. Medicis Pharmaceutical (MRX) stock has been showing support around $42.42...
StreetInsider.com  Nov 16  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Valeant+%28VRX%29+Receives+FTC+Clearance+to+Acquire+Medicis+Pharma+%28MRX%29/7885904.html for the full story.
Market Intelligence Center  Nov 12  Comment 
Medicis Pharmaceutical Corp (NYSE: MRX) closed Friday's trading session at $42.03. In the past year, the stock has hit a 52-week low of $29.76 and 52-week high of $43.70. Medicis Pharmaceutical (MRX) stock has been showing support around $38.42...
StreetInsider.com  Nov 9  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Medicis+%28MRX%29+Slumps+as+Q-Med+Takes+Up+Lawsuit+%28VRX%29/7862876.html for the full story.





You may also be interested in articles related to Medicis Pharmaceutical (MRX):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki